Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease.

Cell cycle (Georgetown, Tex.) - 1 Jan 2014

Aravinthan Aloysious, Mells George, Allison Michael, Leathart Julian, Kotronen Anna, Yki-Jarvinen Hannele, Daly Ann K, Day Christopher P, Anstee Quentin M, Alexander Graeme

Abstract excerpt

Non-alcohol-related fatty liver disease (NAFLD) encompasses a wide spectrum, ranging from steatosis alone to steatohepatitis and fibrosis. Presence of steatohepatitis and fibrosis are key hallmarks of disease progression. Previous studies have demonstrated an association between hepatocyte p21 ex...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Cellular Senescence
Share to Cyclin-Dependent Kinase Inhibitor p21

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to England

Share to Finland

Share to Liver Cirrhosis

Share to Non-alcoholic Fatty Liver Disease

Source

Open in PubMed Open full text

Identifiers

PMID: 24626178
DOI: 10.4161/cc.28471
PMCID: PMC4050146

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24626178-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease.PMID 24626178Read ↗

Hepatocyte senescence predicts progression in non-alcohol-related fatty liver diseaseSemantic proximity Read ↗

Fibroblast growth factor 21 is a hepatokine involved in MASLD progression.Semantic proximity Read ↗

Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.Semantic proximity Read ↗

Hepatocyte Expression of the Senescence Marker p21 Is Linked to Fibrosis and an Adverse Liver-Related Outcome in Alcohol-Related Liver DiseaseSemantic proximity Read ↗

Genetic Markers Predisposing to Nonalcoholic Steatohepatitis.Semantic proximity Read ↗

The association of genetic polymorphisms with nonalcoholic fatty liver disease in a longitudinal study.Semantic proximity Read ↗

FBP1 controls liver cancer evolution from senescent MASH hepatocytes.Semantic proximity Read ↗

Hyperinsulinemia Is Highly Associated With Markers of Hepatocytic Senescence in Two Independent CohortsSemantic proximity Read ↗

The efficacy of calcitriol treatment in non-alcoholic fatty liver patients with different genotypes of vitamin D receptor FokI polymorphism.Semantic proximity Read ↗

Genetic influences in nonalcoholic fatty liver disease.Semantic proximity Read ↗

The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease.Semantic proximity Read ↗

The single nucleotide polymorphism rs499765 is associated with fibroblast growth factor 21 and nonalcoholic fatty liver disease in a Chinese population with normal glucose tolerance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.